)
Edge6 Mar 2026
Upvoted: The Story of Reddit
How Reddit built a unique platform around communities and conversation, turning human insight and intent into a distinctive business model.
Anika Therapeutics
Anika Therapeutics (ANIK) investor relations material
Anika Therapeutics 2026 CG Musculoskeletal Conference summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.2026 CG Musculoskeletal Conference summary2 Mar, 2026
Business Overview and Strategy
Focus on differentiated hyaluronic acid-based technologies for joint preservation, OA pain management, and regenerative medicine, with a 33-year track record and robust innovation pipeline.
Strategy centers on accelerating growth via commercial momentum, advancing the new product pipeline, and strengthening operational discipline.
Strong balance sheet with $57.5M in cash at end of 4Q 2025, no debt, and consistent profitability and cash flow, enabling continued investment in new product launches without raising capital.
Commercial channel revenue grew from $26M in 2021 to $48M in 2025, with a 17% CAGR over five years, and is projected to maintain strong double-digit growth.
Three-pronged strategy includes driving top-line growth, advancing the product pipeline, and maintaining operational discipline.
Product Portfolio and Market Position
Core portfolio includes OA pain management products (Orthovisc, Monovisc, Cingal) and regenerative solutions (Integrity, Hyalofast), with a market-leading US viscosupplement portfolio supported by a partnership with J&J MedTech.
Integrity Implant System launched in 2023, achieved $2M in 2024 and $6M in 2025 sales, doubling revenue and exceeding expectations, with superior strength and regenerative capacity.
Hyalofast, a single-stage, off-the-shelf, resorbable scaffold for cartilage repair, sold in 35+ countries with over 40,000 implants, US PMA submitted, and US launch planned for Q4 2027.
Cingal, a next-generation OA pain product, targets a $1B market, has shown statistically superior pain reduction and durability, with over 1 million doses sold OUS and NDA filing expected in 2026.
Proprietary HA technology platform underpins both pain management and regenerative solutions, offering unique advantages in healing and tissue repair.
Clinical and Regulatory Updates
Hyalofast US PMA filing completed third module; secondary endpoints met in clinical trials, supporting ongoing FDA discussions, with US launch planned for 2027.
Cingal completed three phase 3 trials, showing statistical significance; NDA filing in the US pending completion of a bioequivalence study, expected in 2026.
Integrity and Hyalofast leverage HYAFF technology, with plans for further launches and updates as regulatory milestones are reached.
Given Hyalofast's trial results, how will Anika secure US approval?
What strategies mitigate OEM channel revenue decline?
Beyond Cingal, what HA stability R&D is underway?
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Next Anika Therapeutics earnings date
Q1 20268 May, 2026
Anika Therapeutics
Next Anika Therapeutics earnings date
Q1 20268 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Anika Therapeutics Inc. is a medical technology company focused on developing, manufacturing, and commercializing products for joint health and orthopedic applications. The company's offerings include therapeutic solutions for pain management, joint preservation, and tissue repair, utilizing proprietary hyaluronic acid-based technology and other advanced biomaterials. Anika serves healthcare providers, including orthopedic surgeons and clinicians, with a portfolio that addresses conditions such as osteoarthritis and soft tissue injuries. The company is headquartered in Bedford, Massachusetts, and its shares are listed on the NASDAQ.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage